Literature DB >> 8301231

Polydeoxycholate in human and hamster feces: a major product of cholate metabolism.

G M Benson1, N J Haskins, C Eckers, P J Moore, D G Reid, R C Mitchell, S Waghmare, K E Suckling.   

Abstract

Fecal bile acid excretion is one of the two major routes by which cholesterol is eliminated from the body, fecal cholesterol being the other. During their enterohepatic circulation, bile acids are secreted into the duodenum, pass down the jejunum and into the ileum where more than 95% is reabsorbed by the gut. Bile acids that escape reabsorption in the small intestine are metabolized by microorganisms in the large intestine. The major routes of metabolism are reported to be deconjugation, dehydroxylation, especially at the 7 alpha-hydroxy position, and dehydrogenation of the hydroxyl moieties. There are also some reports that saponifiable metabolites containing mostly deoxycholic acid form a major component of the bile acids found in human feces. We have identified a novel metabolite of cholic acid, 3 alpha-hydroxy polydeoxycholate, in both human and hamster feces that is the major constituent of these saponifiable metabolites. Furthermore, we have shown in hamsters that the animals that excreted more bile acid were excreting the additional bile acid as polydeoxycholate. As expected, there was a negative correlation between bile acid excretion in the feces and plasma cholesterol concentrations in these animals. We speculate that polydeoxycholate is formed in the lower gut of both humans and hamsters and that, by its formation, bile acid will be sequestered in an insoluble form, thus inhibiting its reabsorption by the gut. This process may help to reduce plasma cholesterol concentrations and coronary heart disease in humans.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8301231

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  9 in total

1.  A novel ASBT inhibitor, IMB17-15, repressed nonalcoholic fatty liver disease development in high-fat diet-fed Syrian golden hamsters.

Authors:  Mao-Xu Ge; Wei-Xiao Niu; Jin-Feng Ren; Shi-Ying Cai; Dong-Ke Yu; Hong-Tao Liu; Na Zhang; Yi-Xuan Zhang; Yu-Cheng Wang; Rong-Guang Shao; Ju-Xian Wang; Hong-Wei He
Journal:  Acta Pharmacol Sin       Date:  2018-12-20       Impact factor: 6.150

Review 2.  Microbial modulation of cardiovascular disease.

Authors:  J Mark Brown; Stanley L Hazen
Journal:  Nat Rev Microbiol       Date:  2018-01-08       Impact factor: 60.633

Review 3.  Conceptualizing the Vertebrate Sterolbiome.

Authors:  Jason M Ridlon
Journal:  Appl Environ Microbiol       Date:  2020-08-03       Impact factor: 4.792

4.  Production of New Microbially Conjugated Bile Acids by Human Gut Microbiota.

Authors:  Carlos J Garcia; Vit Kosek; David Beltrán; Francisco A Tomás-Barberán; Jana Hajslova
Journal:  Biomolecules       Date:  2022-05-11

Review 5.  Bile acids: analysis in biological fluids and tissues.

Authors:  William J Griffiths; Jan Sjövall
Journal:  J Lipid Res       Date:  2010-01       Impact factor: 5.922

Review 6.  Consequences of bile salt biotransformations by intestinal bacteria.

Authors:  Jason M Ridlon; Spencer C Harris; Shiva Bhowmik; Dae-Joong Kang; Phillip B Hylemon
Journal:  Gut Microbes       Date:  2016

Review 7.  Intestinal transport and metabolism of bile acids.

Authors:  Paul A Dawson; Saul J Karpen
Journal:  J Lipid Res       Date:  2014-09-10       Impact factor: 5.922

8.  A simple and accurate HPLC method for fecal bile acid profile in healthy and cirrhotic subjects: validation by GC-MS and LC-MS.

Authors:  Genta Kakiyama; Akina Muto; Hajime Takei; Hiroshi Nittono; Tsuyoshi Murai; Takao Kurosawa; Alan F Hofmann; William M Pandak; Jasmohan S Bajaj
Journal:  J Lipid Res       Date:  2014-03-13       Impact factor: 5.922

9.  Muricholic acids inhibit Clostridium difficile spore germination and growth.

Authors:  Michael B Francis; Charlotte A Allen; Joseph A Sorg
Journal:  PLoS One       Date:  2013-09-09       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.